DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Sun Pharmaceutical Industries Limited — Acquisition of 'to be incorporated companies'-XBRL

NSE 54 min ago·9 Sept 2026, 9:37 am

SUN Pharmaceutical IND L

Sun Pharmaceutical Industries has informed stock exchanges about the acquisition of 'to be incorporated companies.' This means the company is in the process of acquiring entities that are currently being formed and have not yet legally come into existence.

This move is significant as it signals the company's intent to expand its business footprint. For investors, it suggests a strategic focus on growth and the potential to acquire valuable assets or capabilities before they become fully operational in the market.

Investors should watch for the formal incorporation of these companies and the subsequent disclosure of the deal's financial terms. This will provide clarity on the investment's size and the strategic value it adds to Sun Pharma's portfolio.